Protective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidity - Wikidata - wikimedia - TriplyDB

Protective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidity

Protective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidity

http://www.wikidata.org/entity/Q24630655

about

The possibilities and principles of methotrexate treatment of psoriasis - the updated knowledge.Preventing Heart Failure in Inflammatory and Immune Disorders Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion.Effects of TNFα inhibitors on adiposity and other cardiovascular risk factors: implications for the cardiovascular prognosis in patients with rheumatoid arthritis.Lipid and Metabolic Changes in Rheumatoid Arthritis.Preventive Role of Tetraspanin CD9 in Systemic Inflammation of Chronic Obstructive Pulmonary Disease.Reincarnated medicines: using out-dated drugs for novel indications.Comparison of comorbidities of the Egyptian rheumatoid arthritis patients to the global cohort of the COMORA study: a post-hoc analysis.Atherothrombosis is a Thrombotic, not Inflammatory Disease.Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studies.The effect of subcutaneous methotrexate on markers of metabolic syndrome in psoriatic patients - preliminary report.

P2860

Q34945967-148321C1-11EC-46FA-B024-F9A4C5827AB7 Q35994802-B770A0C1-73DC-4488-BBAD-995DED253636 Q37058791-7476597B-F8E2-414D-BA8C-383F759561D9 Q38323310-90393CCB-A287-41BE-90B3-5D2036074EBD Q38554197-140FC30D-E894-4D70-973B-1428F61F8449 Q38588362-22DBE4CD-E2F1-48FD-ACE7-0F4EFF9FED49 Q38766355-ABB87798-08C7-4D91-AE9B-6E47DB74B728 Q38990549-689D2B26-3019-43FF-BF85-4A0C0E0F58B6 Q49474668-87A46F77-5E48-4415-9EEC-9420C3B067D6 Q49792187-8901901B-9E1E-49C4-951F-F8A4FFEBD83F Q51243846-0FB9D842-255E-4FB2-B123-4AC283A773E4

P2860

Protective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidity

http://www.wikidata.org/entity/Q24630655

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Protective effect of methotrex ...... and cardiovascular comorbidity

@ast

Protective effect of methotrex ...... and cardiovascular comorbidity

@en

Protective effect of methotrex ...... and cardiovascular comorbidity

@nl

type

label

Protective effect of methotrex ...... and cardiovascular comorbidity

@ast

Protective effect of methotrex ...... and cardiovascular comorbidity

@en

Protective effect of methotrex ...... and cardiovascular comorbidity

@nl

prefLabel

Protective effect of methotrex ...... and cardiovascular comorbidity

@ast

Protective effect of methotrex ...... and cardiovascular comorbidity

@en

Protective effect of methotrex ...... and cardiovascular comorbidity

@nl

P1433

Q24630655-F3B61D43-3DAB-489C-AC68-B998BCB5F1E4

P1476

Q24630655-286910E7-EC19-42BB-91EF-CDF7EFB47D96

P2093

Q24630655-E7928B6F-7813-4278-846C-D8C4D375951E

Q24630655-EA890083-A2EF-48DB-809E-921EC165AF2B

P2860

Q24630655-01596E8F-8009-4E75-A6D5-C1E0C4C7F0CA

Q24630655-0A866124-7C90-4E6D-BDF5-4A5C739D10A2

Q24630655-0DE6634B-6007-4DFF-9D82-AF1D321E1C9F

Q24630655-0EF8C21C-2BBF-44F6-A38B-617AB1749D59

Q24630655-12FC8B27-2C33-4B6D-AC9C-2E69A9279E9E

Q24630655-1455FF99-B6C0-4642-BEBE-6FA6F9ADFFED

Q24630655-243E9977-77B6-4AA3-8A9E-030532342F05

Q24630655-2CFB8686-C82C-4C08-B1D6-BB81A7BD3933

Q24630655-301238B5-46AA-43E4-8EDD-FAF5DEF00DFF

Q24630655-31128C32-9D67-4F3E-8498-C453AF40EFF7

P304

Q24630655-C20BDF11-9474-43E6-B069-8445C864E11E

P31

Q24630655-EFB7EDDF-C5A9-42F2-8B2C-D95026878049

P356

Q24630655-E3AEC6FC-4FDB-4AC1-8A39-4F3C0118C966

P407

Q24630655-DDA75DD7-F94A-44C3-987D-23C6EF7AD75C

P433

Q24630655-94A8F5F8-E367-411E-BDF2-58EA36907A3C

P478

Q24630655-5435AD8D-6073-49BA-A4DB-8AE89E1A1988

P577

Q24630655-DD60D38D-C458-4808-987D-2D6EEE985162

P698

Q24630655-9682D667-EDF6-4495-88C8-D3D09E6E8648

P921

Q24630655-C6B9EBE6-0218-4C9C-AD1A-5AA4D3B8ACB7

Q24630655-E938E6EA-50F1-4469-90FD-0722C3B29398

P932

Q24630655-67B67586-26B8-4D12-A924-7220281D2471

P356

1759720X11436239

P1433

Therapeutic advances in musculoskeletal disease

P1476

Protective effect of methotrex ...... and cardiovascular comorbidity

@en

P2093

Christopher J Edwards

http://www.w3.org/2001/XMLSchema#string

Jonathan L Marks

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

How does methotrexate suppress inflammation?

Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis.

Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis.

Inflammatory pathways in atherosclerosis and acute coronary syndromes.

Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease

MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis.

Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?

Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies.

P304

149-57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1759720X11436239

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22850632

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

3400102

http://www.w3.org/2001/XMLSchema#string